CD276 and acute myeloid leukemia: Overall, the results show that our cytotoxic anti-B7-H3 affibody possesses strong antiproliferative and cell death-inducing activity that is highly specific to B7-H3-expressing AML cells (IC50 against THP-1 cells was 26.35 μM).